Scavilla Daniel T

GMED CEO Scavilla dumps entire 130,000 share stake ($11.0M) at $85.00; now holds 0 shares

On 2024-11-21, President and CEO Daniel T. Scavilla sold all 130,000 shares of GLOBUS MEDICAL INC at $85.00 per share for a total value of $11,050,000.00, reducing his holdings from 130,000 shares to 0 shares—a complete exit at -0.5% from the 52-week high of $84.91. This sale is material in absolute terms and follows a prior sale at the same company just 15 days earlier (2024-11-06), suggesting sustained portfolio reduction by the chief executive. The timing occurs in a context of strong recent stock performance (30-day change: +15.5%, 90-day change: +17.8%) and robust fundamentals including $625.7M in latest quarterly revenue, $51.8M in net income, and annual revenue growth of +53.3%, though the elevated P/E of 126.10 may reflect expectations already priced into the market. The complete liquidation by the CEO warrants attention as a data point, particularly given the sequential nature of the two recent sales.

GMED CEO Scavilla sells entire 60,000-share position ($4.8M) at $80.02; zero holdings post-transaction

CEO Daniel T Scavilla liquidated his complete stake in GLOBUS MEDICAL, disposing of 60,000 shares for $4,801,200.00 and retaining zero shares thereafter. This represents a 100% exit from personal holdings at $80.02 per share, just 2.2% below the 52-week high of $82.71, while the stock is up 14.8% over the prior 30 days and 10.5% over 90 days. The company trades at a P/E of 120.72 with a market cap of $11.0B and demonstrated strong recent momentum (up from a 52-week low of $43.79), yet the CEO's complete departure from ownership is a structural signal that warrants careful investor review of his stated rationale in the filing and the company's forward guidance.